CO-NEWMONT-CORPORATION
Newmont Corporation (NYSE: NEM, TSX: NGT, ASX: NEM, PNGX: NEM) proudly announces the successful completion of the $20 million Global Community Support Fund (the Fund), established in April 2020 in response to the unprecedented challenges posed by the global pandemic. The objective of this fund was to provide critical financial resources to host communities where Newmont operates, targeting funds to address immediate impacts of the global pandemic while catalyzing long-term resiliency and future community development.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240404566254/en/
“After almost four years since its launch, we are pleased to announce the successful closure of the Global Community Support Fund, which reflects our ongoing commitment to partnering with the communities where we operate,” said Suzy Retallack, Chief Safety and Sustainability Officer at Newmont. “The Fund’s impact has been far-reaching, contributing to the collective efforts of communities to overcome the challenges posed by the pandemic and innovate for greater resilience in the future.”
Over the past 3.5 years, Newmont has partnered with more than 420 local governments, medical institutions, charities, and non-governmental organizations to strategically allocate funds effectively. The $20 million Fund has been instrumental in supporting a wide range of initiatives, focused on health, food security and economic resilience:
- $1.4 million donated to the Regional Hospital of Cajamarca, providing ventilators, incubators, monitoring equipment, COVID-19 tests and personal protective equipment (PPE).
- $500,000 donation matched by the Colorado Health Foundation resulting in a $1 million total donation to the Colorado Community Support Fund to support community health and prevention for underserved populations in the state.
- $300,000 donated to the American Red Cross Global Disaster Preparedness Center to support research and local-level grants for emergency response community resilience.
- $304,000 donated to the Cree Trappers' Association in Quebec to provide food security to vulnerable people and employment for traditional harvesters in the nine communities of Eeyou Istchee.
- $734,000 donated to the Kumasi Centre for Collaborative Research in Ghana to establish two new laboratories in the host communities of Ahafo and Akyem along with COVID-19 tests and testing equipment to expand their testing capacity for COVID-19 and other infectious diseases.
- $968,000 donated to Suriname’s Ministry of Health to launch the Recovery and Resilience Project in partnership with Crown Agents to strengthen Suriname’s health system, reduce non-communicable diseases (NCDs) and COVID-19 burdens, and enhance emergency response capabilities.
"As part of our commitment to addressing the challenges posed by non-communicable diseases (NCDs) and the impact of COVID-19 in Suriname, Crown Agents, the Ministry of Health and Newmont formed an impactful partnership on the Recovery and Resilience Project. Together, we worked to strengthen Suriname's health system, alleviate the burden of NCDs and COVID-19, and enhance emergency response capabilities,” says Sarah Hepworth, Chief Programmes Officer at Crown Agents. “Our focus on strengthening NCD services, promoting vaccination uptake, and addressing healthcare worker hesitancy underscores our dedication to improving the well-being of the people of Suriname. Crown Agents is proud to collaborate with Newmont and the Ministry of Health to contribute to the health and resilience of Suriname."
Newmont remains committed to its core values of safety, sustainability, and responsibility, and the successful implementation of the Global Community Support Fund underpins the company’s purpose to create value and improve lives through sustainable and responsible mining.
About Newmont
Newmont is the world’s leading gold company and a producer of copper, zinc, lead, and silver. The company’s world-class portfolio of assets, prospects and talent is anchored in favorable mining jurisdictions in Africa, Australia, Latin America & Caribbean, North America, and Papua New Guinea. Newmont is the only gold producer listed in the S&P 500 Index and is widely recognized for its principled environmental, social, and governance practices. Newmont is an industry leader in value creation, supported by robust safety standards, superior execution, and technical expertise. Founded in 1921, the company has been publicly traded since 1925.
At Newmont, our purpose is to create value and improve lives through sustainable and responsible mining. To learn more about Newmont’s sustainability strategy and initiatives, go to www.newmont.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240404566254/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
The 2025-2026 World Branding Awards Animalis Edition Honouring Leading Pet and Animal Brands Globally3.7.2025 21:00:00 CEST | Press release
The 2025-2026 World Branding Awards Animalis Edition marked its fifth instalment, bringing together leading pet and animal brands from all around the world. These brands were celebrated for their outstanding achievements, earning recognition as National, Regional, and Global Winners. The awards ceremony, held at Vienna's prestigious Hofburg Palace, welcomed winners across diverse categories, including pet food, retail, wellness, pet exhibitions, and aquatic products. Mounia Berrada-Gouzi expertly hosted the evening, which culminated in a grand celebration of brand excellence. “The Animalis Edition of the World Branding Awards recognises brands that have achieved the highest distinction—genuine recognition in the hearts and minds of consumers. Tonight, we honour those whose names resonate globally, whose values inspire loyalty, and whose presence defines excellence in the pet and animal industry,” said Richard Rowles, Chairman of the World Branding Forum. Out of over 950 brands nominate
Venture Global Announces 20-Year Sales and Purchase Agreement with PETRONAS3.7.2025 14:59:00 CEST | Press release
Today, Venture Global, Inc. (NYSE: VG) announced the execution of a new 20-year Sales and Purchase Agreement (SPA) with PETRONAS LNG Ltd. (PLL), a subsidiary of the Malaysian state-owned oil and gas company, PETRONAS. Under the terms of the SPA, PETRONAS will purchase 1 million tonnes per annum (MTPA) of liquefied natural gas (LNG) from Venture Global’s third facility, CP2 LNG, for 20 years. This builds upon Venture Global’s existing agreement with PETRONAS for 1 MTPA of LNG supply from Plaquemines LNG. PETRONAS, a world-class partner in the LNG industry, joins other CP2 LNG customers in Europe, Asia and the rest of the world in a strategically important project to global energy supply and security. To date, approximately 10.75 MTPA of the 14.4 MTPA nameplate capacity for CP2 Phase One has been sold. About Venture Global Venture Global is a long-term, low-cost provider of U.S. LNG sourced from resource rich North American natural gas basins. Venture Global’s business includes assets ac
Frost & Sullivan Recognizes Novotech as 2025 Global Biotech CRO Company of the Year3.7.2025 14:05:00 CEST | Press release
In recognition of its innovation, client-focused delivery, and global impact, Novotech has been awarded the 2025 Global Biotechnology Contract Research Organization (CRO) Company of the Year by Frost & Sullivan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250703950144/en/ Novotech Wins Global CRO Award Novotech is a globally recognized full-service clinical CRO and scientific advisory firm, trusted by biotech and small- to mid-sized pharmaceutical companies to advance their drug development programs at every phase. With a global footprint spanning Asia-Pacific, North America, and Europe, Novotech supports over 5,000 clinical trial sites and a distributed team of experts delivering seamless, end-to-end solutions across geographies. “Novotech is redefining biotech-focused clinical research through AI-driven innovation, global expansion, and a client-embedded partnership model. With a clear vision to be the CRO of choice for
Tinnitus Research: Novel Compound AC102 Makes Constant Ear Noise Disappear in Preclinical Model3.7.2025 12:02:00 CEST | Press release
The novel compound AC102 almost completely reversed tinnitus in a preclinical model after a single dose. At the same time, the damaged connections between the auditory nerve and inner ear sensory cells were restored. These findings were recently published in the prestigious International Journal of Molecular Sciences in a joint study conducted by Erlangen University Hospital and Berlin-based drug developer AudioCure. As there is currently no causal treatment for tinnitus, there is a high medical need. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702168211/en/ In 10-20% of tinnitus cases, the noise in the ear is so severe that it significantly impairs the quality of life of those affected. (Source: AI-generated) In the current study, AC102 was administered to the middle ear of one experimental group after acoustic trauma, while a second group received a placebo. Although both groups initially showed signs of tinnitus, th
H2SITE Secures EIC Accelerator Funding to Deploy a Flagship 1 TPD Ammonia Cracker Using Membrane Reactor Technology at a Port in North-West Europe3.7.2025 08:40:00 CEST | Press release
H2SITE has been awarded the EIC (European Innovation Council) Accelerator program for a project aimed at deploying a first-of-its-kind ammonia cracking unit capable of producing 1 ton of high-purity hydrogen per day. The system is based on H2SITE’s proprietary palladium-based membrane reactor technology, which enables the simultaneous catalytic decomposition of ammonia and selective hydrogen separation within a single unit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250702142283/en/ Ammonia Cracker using Membrane Reactor Technology This breakthrough technology offers several compelling advantages over conventional ammonia cracking processes: Lowest Levelized Cost of Hydrogen (LCOH) from ammonia due to high efficiency and integrated operation Reduced energy consumption, operating at significantly lower temperatures (400–450 °C) than traditional cracking methods (typically 600–800 °C) High-purity hydrogen output, compliant
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom